Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating secretory component in breast neoplasms.

D Kvale, T O Rognum, E Thorud

    Journal of Clinical Pathology
    |June 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    T Cell Responses and Regulation and the Impact of In Vitro IL-10 and TGF-β Modulation During Treatment of Active Tuberculosis.

    Scandinavian journal of immunology·2016
    Same author

    IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy.

    The Journal of infection·2015
    Same author

    Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection.

    Clinical and experimental immunology·2014
    Same author

    Markers of microbial translocation predict hypertension in HIV-infected individuals.

    HIV medicine·2013
    Same author

    Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.

    Clinical and experimental immunology·2010
    Same author

    Predictive value of immunologic parameters and HIV RNA in relation to humoral pneumococcal polysaccharide vaccine responses in patients with HIV infection.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2002

    Secretory Immunoglobulin M (SIgM) shows promise as a breast cancer biomarker, demonstrating higher sensitivity than secretory Immunoglobulin A (SIgA) in detecting carcinomas. High SIgM and SIgA levels were observed in patients with liver metastases.

    Area of Science:

    • Oncology
    • Immunology
    • Biochemistry

    Background:

    • Breast neoplasms represent a significant health concern, necessitating improved diagnostic markers.
    • Secretory immunoglobulins, including secretory Immunoglobulin A (SIgA) and secretory Immunoglobulin M (SIgM), are involved in mucosal immunity and have been investigated as potential biomarkers.

    Purpose of the Study:

    • To evaluate the diagnostic potential of serum concentrations of SIgA and SIgM in patients with breast neoplasms.
    • To compare the sensitivity of SIgA and SIgM as markers for breast carcinoma.

    Main Methods:

    • Serum concentrations of SIgA and SIgM were measured in 98 patients with breast neoplasms.
    • Analysis included patients with carcinomas, benign tumors, and assessment of correlations with tumor characteristics and other biomarkers.

    Related Experiment Videos

    Main Results:

    • Elevated SIgM concentrations were found in 11 of 56 patients with breast carcinoma, showing nearly twice the sensitivity of SIgA.
    • SIgA and SIgM levels were largely independent of tumor grade, DNA ploidy, and secretory component expression, but showed a weak correlation with circulating carcinoembryonic antigen (CEA).
    • Patients with liver metastases exhibited particularly high SIgA and SIgM concentrations.

    Conclusions:

    • Circulating SIgM is a potentially more sensitive serum biomarker for breast carcinoma than SIgA.
    • Further research is warranted to explore the clinical utility of SIgM and SIgA in breast cancer diagnostics and monitoring, especially in cases with metastatic disease.